학술논문
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies.
Document Type
Journal Article
Author
van Tilburg, Cornelis M.; Witt, Ruth; Heiss, Melanie; Pajtler, Kristian W.; Plass, Christoph; Poschke, Isabel; Platten, Michael; Harting, Inga; Sedlaczek, Oliver; Freitag, Angelika; Meyrath, David; Taylor, Lenka; Balasubramanian, Gnana Prakash; Jäger, Natalie; Pfaff, Elke; Jones, Barbara C.; Milde, Till; Pfister, Stefan M.; Jones, David T. W.; Kopp-Schneider, Annette
Source
Subject
*GENETIC load
*INVESTIGATIONAL therapies
*TEENAGERS
*PROGRAMMED death-ligand 1
*DRUG development
CENTRAL nervous system tumors
*
*
*
*
Language
ISSN
1471-2407
Abstract